Zhitong Finance App News, Puluo Pharmaceutical (000739.SZ) announced that the company's holding subsidiary Zhejiang Anteyutai Biotechnology Co., Ltd. (hereinafter referred to as “Anteyutai” or “Party A”), Shanghai Pharmaceutical Biotechnology Co., Ltd. (hereinafter referred to as “Pharmaceutical Biotech” or “Party B”) and Shanghai Duoning Biotechnology Co., Ltd. (hereinafter referred to as “Doning Biotech” or “Party C”) recently signed a “Strategic Cooperation Framework Agreement”. The three parties intend to establish a long-term strategic cooperation framework agreement on the premise of complying with applicable laws, regulations, regulatory requirements and business ethics, stable and open strategic partnerships It promotes Party A's biomacromolecule drug pipeline development, industrialization capacity building, and supply chain system improvement through resource collaboration and complementary advantages.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.